Orbeseal Dry Cow 2.6g Intramammary Suspension

Selection of cows for treatment with the veterinary medicinal product should
be based on veterinary clinical judgement. Selection criteria may be based on
the mastitis and cell count history of individual cows or recognised tests for
the detection of subclinical mastitis or bacteriology sampling.

Special precautions for safe use in the target species:
It is good practice to observe dry cows regularly for signs of clinical mastitis. If
a sealed quarter develops clinical mastitis, the affected quarter should be
stripped out manually before appropriate therapy is instituted.
To reduce the risk of contamination, do not immerse the syringe in water.
Use the syringe only once.
Since the veterinary medicinal product does not have antimicrobial activity, in
order to minimize the risk of acute mastitis due to poor infusion technique and
lack of hygiene (see section 4.6), it is crucial to follow the aseptic technique of
administration described in section 4.9.
Do not administer any other intramammary product following administration of
-the product. In cows that may have sub-clinical mastitis, the veterinary
medicinal product may be used following administration of a suitable dry cow
antibiotic treatment to the infected quarter.
Special precautions to be taken by the person administering the veterinary
medicinal product to animals:
This veterinary medicinal product may cause skin and eye irritation.
Avoid contact with skin or eyes.
Should skin or eye contact occur, wash the affected area thoroughly with
water.
If irritation persists, seek medical advice and show this label to the physician.
People with known hypersensitivity to bismuth salts should avoid contact with
the veterinary medicinal product.
Wash hands after use.
Special precautions for the protection of the environment:
Not applicable.